Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Apollo Hospitals Enterprise Earnings Call: Key Takeaways

Apollo Hospitals delivered strong FY26 performance with 16% revenue growth and 34% PAT growth. Expansion strategy focuses on adding 2,800+ beds by FY30.

Highlights
Revenue growth16% YoY growth for FY26.
MarginsHealthcare services margins stable at 24.5%; HealthCo Online EBITDA improving.
Demand visibilityStrong; inpatient volumes grew 7% in Q4FY26.
Management confidenceHigh, driven by bed occupancy and digital health monetization.

Growth

FY26 Consolidated Revenue reached ₹252,285M (+16% YoY); EBITDA at ₹37,693M (+25%); PAT at ₹19,415M (+34%).

Outlook

Capex plan to add 3,415 total beds (₹6,714cr cost). Aiming for 13,100 total census beds post-expansion.

Risks

New hospital pre-operative losses (₹414M in Q4), regulatory impacts from New Labour Code, and pharmacy competitive intensity.

Source

Earnings Call filed with NSE, NSE: APOLLOHOSP. Summary written with AI assistance from the document.

Read the document ↗

Apollo Hospitals Enterprise Ltd: key numbers

Share price
₹8,889.00
Market cap
₹1,27,810 Cr
Revenue (annual)
₹25,228 Cr
Net profit (annual)
₹1,942 Cr
P/E (TTM)
61.2×Sector 57.8×
Promoter holding
28.02%+0.00% QoQ
FII holding
41.49%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Apollo Hospitals Enterprise Ltd

All →